Meta ads for telehealth: the GLP-1 rules that apply to your ads

Meta ads for telehealth brands selling GLP-1 programs answer to four rule sets: prescription drug authorization (LegitScript plus Meta approval, adults 18+ in the US, Canada or New Zealand), weight-loss creative rules, limits on health data sent through the Pixel and Conversions API, and identity rules for doctors and AI presenters. A restricted ad account has its own review process.

Policy checked on October 24, 2026.

Start here: find the Meta rule for what you see

• If your ad names semaglutide, tirzepatide or a branded GLP-1, or shows a drug price → Meta’s prescription drug rules for GLP-1 ads
• If your creative shows bodies, weight numbers, a before-and-after or a “results in 4 weeks” line → Meta’s weight loss ads policy as of July 2026
• If conversions dropped, events were blocked or Events Manager mentions “core setup” → how Meta restricts health data from telehealth sites
• If a doctor, an actor in scrubs or an AI avatar speaks in your ad → AI-generated and fake doctors in GLP-1 ads
• If Meta restricted your ad account, Page or business portfolio → how a restriction review works, further down this page

Which Meta policy covers each part of a GLP-1 ad

One GLP-1 ad can fall under several Meta policies at the same time, and each one lives on its own page with its own change log. Meta doesn’t publish a combined view, so we built one from its pages. Dates are the latest entry each page showed on October 24, 2026.

Health and Wellness doesn’t cover prescription authorization or tracking, so a team that checks only that page misses two of the four rule sets. The help pages that decide what happens to your conversion data show no dates at all. If Meta edits one of them, no change log will tell you. Targeting has its own rule outside the Ad Standards: starting January 19, 2022, Meta removed Detailed Targeting options that relate to health topics, with examples such as “World Diabetes Day” and “Chemotherapy.” In the same post, Meta pointed advertisers to broad targeting such as age and gender, Engagement Custom Audiences and lookalikes instead. Our Meta media team checks every GLP-1 ad against this same map before launch.

What changed recently in Meta’s GLP-1 ad rules

Checked on October 24, 2026. Newest first.

Meta’s prescription drug rules for GLP-1 telehealth

A GLP-1 telehealth brand can promote a prescription drug only after it holds active LegitScript certification and Meta has authorized it. Meta’s Help Center says: “Promoting prescription drugs is not allowed without authorization from Meta.” The Drugs and Pharmaceuticals page limits those ads to people 18 or older in the United States, Canada or New Zealand, only in countries where the brand is certified (how LegitScript certification works), and requires a disclaimer to consult a licensed health professional or obtain a valid prescription. Meta exempts ads that only promote “telehealth services generally” but doesn’t say where that ends once a GLP-1 is implied; Meta’s prescription drug ads policy for GLP-1 telehealth covers that gray zone and the request steps.

Meta’s weight loss ad rules after July 22, 2026

Meta’s Health and Wellness standard requires ads for weight-loss products and services, GLP-1 programs included, to target people at least 18 years old. The banned list includes negative statements that “attack an individual’s appearance, specific body parts, or hygiene,” close-ups of pinched fat, claims to cure diabetes, and promises of results within a set timeframe without qualifiers. The old side-by-side ban is gone, and Meta doesn’t say those images are now allowed. A separate personal attributes policy rules out copy implying the viewer has a health condition. Facebook ads for weight loss built from 2025 guides may follow wording that no longer exists. The old and new text are compared in Meta’s weight loss ads policy for GLP-1 brands.

Meta’s health data restrictions on telehealth tracking

Meta’s Events Manager can place a GLP-1 telehealth site in its “Health and wellness” data source category, and Meta’s definition names a “telemedicine platform.” A restricted category may get one or more of three limits. Core setup restricts custom parameters and the parts of a URL after the domain. The second limit blocks specific mid and lower funnel standard events. Under full restrictions, the Business Tools can’t be used for ads where the restriction applies. Moving events server-side doesn’t change this, because Meta’s data use requirements cover the Pixel and the Conversions API alike. Effects on audiences and reporting, and how to contest a category, are in Meta health data restrictions for GLP-1 telehealth.

Doctors and AI spokespeople in GLP-1 ads on Meta

Meta lets advertisers use AI-made creative, but its Community Standards remove accounts and Pages that impersonate someone by “using their image(s), name, or likeness with the aim to deceive others.” Its Ad Standards also list unauthorized endorsements as a prohibited commercial practice. The FTC adds its own test. Under 16 CFR 255.3, an endorser an ad presents as an expert must really have that expertise, which catches actors and avatars in white coats. Before launch, ask who the viewer thinks is talking and whether that’s true. The full check, with FDA and New York law, is in AI-generated doctor ads in GLP-1.

When Meta restricts a telehealth ad account

When Meta restricts a GLP-1 brand’s ad account, Page or business portfolio, the official route is a review request in Business Support Home: open Account status overview, select the account, then Request review. Only an admin can file it. Meta says the review is typically done in 48 hours, sometimes longer. The number of requests is limited, and the decision is final once made. After reinstatement, ads that ran before the restriction stay off until you turn them back on in Ads Manager (Meta). A single rejected ad has its own review, which Meta aims to decide within 48 hours (Meta). The full sequence, from the first notice to prevention, is in what to do when Meta disables a telehealth ad account.

Press and regulator attention on GLP-1 ads on Meta

GLP-1 ads on Meta have drawn press and government attention since 2023. On June 15, 2023, NBC News counted more than 4,000 active US campaigns on Facebook and Instagram that mentioned semaglutide. After NBC asked Meta about them, the count fell to about 560, which NBC called “a decline of 88% from Tuesday.” On July 20, 2023, the FTC and HHS warned about 130 hospital systems and telehealth providers about tracking tools including “the Meta/Facebook pixel.” On December 17, 2025, Arizona’s attorney general and 35 others asked Meta to enforce its own policies. Their letter also asked Meta to “restrict prescription drug ads in the United States to only those that are FDA-approved,” which would shut out compounded GLP-1 offers if Meta adopted it. Meta’s Drugs and Pharmaceuticals page shows no such change as of October 24, 2026.

FAQ

What is Meta’s healthcare advertising policy for GLP-1 brands? For a GLP-1 brand, Meta’s healthcare advertising rules sit in five places: Drugs and Pharmaceuticals, Health and Wellness, Privacy Violations and Personal Attributes, the Events Manager data category pages and the identity standards. The map table above shows which one owns which part of an ad.

Does Meta allow AI ads? Yes. Meta’s help page names one case where advertisers must disclose AI use, ads “about social issues, elections or politics,” and Meta adds its own “AI info” label to some AI-made ads. Deceptive likeness and fake endorsements are banned whether or not AI made them.